115 related articles for article (PubMed ID: 32831196)
1. Investigation of GSTP1 and epigenetic regulators expression pattern in a population of Iranian patients with prostate cancer.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Hum Antibodies; 2020; 28(4):327-334. PubMed ID: 32831196
[TBL] [Abstract][Full Text] [Related]
2. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Hormone Therapy on the Expression of Prostate Cancer and Multi-Epigenetic Marker Genes in a Population of Iranian Patients.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Cancer Manag Res; 2020; 12():3691-3697. PubMed ID: 32547205
[TBL] [Abstract][Full Text] [Related]
4. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.
Zhang W; Jiao H; Zhang X; Zhao R; Wang F; He W; Zong H; Fan Q; Wang L
Mol Med Rep; 2015 Jul; 12(1):141-6. PubMed ID: 25738352
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
[TBL] [Abstract][Full Text] [Related]
8. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
9. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
Jerónimo C; Usadel H; Henrique R; Oliveira J; Lopes C; Nelson WG; Sidransky D
J Natl Cancer Inst; 2001 Nov; 93(22):1747-52. PubMed ID: 11717336
[TBL] [Abstract][Full Text] [Related]
11. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
[TBL] [Abstract][Full Text] [Related]
12. piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation.
Zhang L; Meng X; Pan C; Qu F; Gan W; Xiang Z; Han X; Li D
Cell Signal; 2020 Mar; 67():109501. PubMed ID: 31837464
[TBL] [Abstract][Full Text] [Related]
13. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
[TBL] [Abstract][Full Text] [Related]
14. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Clinicopathological Aspects of Prostate Cancer in Bulgarian Probands.
Tsvetkova A; Todorova A; Todorov T; Georgiev G; Drandarska I; Mitev V
Pathol Oncol Res; 2015 Sep; 21(4):969-76. PubMed ID: 25753984
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
Meiers I; Shanks JH; Bostwick DG
Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.
Vo TT; Ta BT; Ta VT; Vuong DL; Nguyen QU
Turk J Med Sci; 2016 Jan; 46(1):228-35. PubMed ID: 27511358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
